Biomerica, Inc. announced that the American Medical Association's CPT editorial panel has granted a Proprietary Laboratory Analysis (PLA) code for its inFoods® IBS test, which personalizes the ...

“A real-world assessment of healthcare resource utilization following IBS-Smart® and Trio-Smart® testing in patients with suspected irritable bowel syndrome,” by Leonard Weinstock, William B. Salt II, ...

IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company ...

Biomerica applies for a PLA code to enhance patient access to its inFoods IBS diagnostic test for personalized IBS management. Biomerica, Inc. has submitted an application to the American Medical ...

Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel Syndrome (IBS) may experience significant relief from ...

Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to experience less abdominal pain if they followed a diet guided by the ...

Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to experience less abdominal pain if they followed a diet guided by the ...

The expert panel agreed that the VAS-IBS gives a good picture of how a patient with IBS might feel, and all members except one thought that the VAS-IBS might be useful in clinical practice. Agreement ...

Does knowing the diagnostic criteria necessarily lead to sound clinical decision-making? Not always. A recent study published in Neurogastroenterology & Motility evaluated medical students from 14 ...

ST. LOUIS & DUBLIN, Ohio & MESA, Ariz., August 18, 2026--(BUSINESS WIRE)--Gemelli Biotech today announced the publication of a real-world study in Frontiers in Gastroenterology evaluating healthcare ...